[A four-year follow-up study of hepatocellular carcinoma with bone metastasis].
A 68-year-old male was admitted to hospital for treatment of a hepatocellular carcinoma with a bone metastasis. By TAE and the administration of PSK, the tumor was necrotized and the AFP level returned to normal range. We presume that this combination therapy of TAE and PSK was able to maintain normal cellular immunity and bring about this good result.
Matsuzaki
T
T
Dept. of Int. Med., Fukuoka Prefectural Hospital.
Nakashima
Y
Y
Ikegami
M
M
Okubo
H
H
Hino
K
K
Emura
T
T
Shinkawa
G
G
Hirai
K
K
Abe
H
H
Tanikawa
K
K
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000556:secondary* / Q000628:therapy; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005500:Follow-Up Studies; D006801:Humans; D007111:Immunity, Cellular; D008113:Liver Neoplasms / Q000276:immunology / Q000473:pathology* / Q000628:therapy; D008297:Male; D011509:Proteoglycans / Q000627:therapeutic use; D013125:Spinal Neoplasms / Q000276:immunology / Q000556:secondary* / Q000628:therapy; D013904:Thoracic Vertebrae
D000276:Adjuvants, Immunologic; D011509:Proteoglycans; C010770:polysaccharide-K